CA Patent

CA3002494C — Compositions for treating spinal muscular atrophy

Assigned to F Hoffmann La Roche AG · Expires 2021-01-12 · 5y expired

What this patent protects

The present invention provides pharmaceutical compositions comprising a compound of formula (I) (see formula I) wherein A, R1, R2 and R3 are as described herein, as well as pharmaceutically acceptable salts thereof. Further the present invention is concerned with the manufacture …

USPTO Abstract

The present invention provides pharmaceutical compositions comprising a compound of formula (I) (see formula I) wherein A, R1, R2 and R3 are as described herein, as well as pharmaceutically acceptable salts thereof. Further the present invention is concerned with the manufacture of the pharmaceutical compositions comprising a compound of formula (I) and their use for treatment, prevention, delaying progression and/or amelioration of spinal muscular atrophy (SMA).

Drugs covered by this patent

Patent Metadata

Patent number
CA3002494C
Jurisdiction
CA
Classification
—
Expires
2021-01-12
Drug substance claim
No
Drug product claim
No
Assignee
F Hoffmann La Roche AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.